Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2017

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Show Description +

David S. Boyer, MD, provides an overview of the phase 2 DEL MAR study with ALG-1001 (Luminate, Allegro) in patients with diabetic macular edema. With stage 1 of the study previously presented, Dr. Boyer details the recent findings of stage 2, which evaluated the safety and efficacy of ALG-1001 with bevacizumab (Avastin, Genentech) pretreatment or ALG-1001 combined with bevacizumab.

Posted: 8/09/2017

Keywords:

luminate

Up Next

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Novel Technique for Steroid Injection

Novel Technique for Steroid Injection

Michael Singer, MD

Treatments for VMT

Treatments for VMT

Nathan C. Steinle, MD

Remaining Cost Effective with 'Slurry' Kenalog

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Novel Technique for Visual Recovery Testing

Novel Technique for Visual Recovery Testing

John B. Miller, MD

Real-World Outcomes of Anti-VEGF Therapy in DME

Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Intraoperative OCT in Subretinal Therapeutic Delivery

Intraoperative OCT in Subretinal Therapeutic Delivery

Lejla Vajzovic, MD

Cytogenetics in Uveal Melanoma

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Revisiting VISTA: Nonperfusion and Aflibercept

Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD

Açai-based Surgical Dye

Açai-based Surgical Dye

Mauricio Maia, MD, PhD

Back to All Videos

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

David S. Boyer, MD, provides an overview of the phase 2 DEL MAR study with ALG-1001 (Luminate, Allegro) in patients with diabetic macular edema. With stage 1 of the study previously presented, Dr. Boyer details the recent findings of stage 2, which evaluated the safety and efficacy of ALG-1001 with bevacizumab (Avastin, Genentech) pretreatment or ALG-1001 combined with bevacizumab.

Posted: 8/09/2017

Keywords:

luminate

Please log in to leave a comment.

More From ASRS: 2017 Coverage

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2017.